Collegium Pharmaceutical, Inc. (COLL) Stock buybacks 2021–2025
Collegium Pharmaceutical, Inc. (COLL) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$25.1MFY2025 · since FY2021: $47.9M → $25.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $25.1M | -58.2% |
| FY2024 | $60.0M | -20.0% |
| FY2023 | $75.0M | +433.3% |
| FY2022 | $14.1M | -70.6% |
| FY2021 | $47.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More COLL financial trends
COLL RevenueCOLL Net incomeCOLL Net marginCOLL Gross profitCOLL Gross marginCOLL Operating incomeCOLL Operating marginCOLL Operating cash flowCOLL Free cash flowCOLL Capital expendituresCOLL Return on equityCOLL Dividends paidCOLL Total assetsCOLL Total liabilitiesCOLL Shareholders’ equityCOLL overview →